Loading...
Loading...
India's efavirenz imports from SINGAPORE total $216 across 10 shipments from 1 foreign suppliers. STRIDES PHARMA GLOBAL PTE. LTD leads with $216 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include STRIDES PHARMA SCIENCE LIMITED. This corridor reflects India's pharmaceutical import demand for efavirenz — a concentrated sourcing relationship with select suppliers from SINGAPORE.

STRIDES PHARMA GLOBAL PTE. LTD is the leading Efavirenz supplier from SINGAPORE to India, with import value of $216 across 10 shipments. The top 5 suppliers — STRIDES PHARMA GLOBAL PTE. LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA GLOBAL PTE. LTD | $216 | 10 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED | $216 | 10 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Efavirenz suppliers from SINGAPORE to India include STRIDES PHARMA GLOBAL PTE. LTD. The leading supplier is STRIDES PHARMA GLOBAL PTE. LTD with import value of $216 USD across 10 shipments. India imported Efavirenz worth $216 USD from SINGAPORE in total across 10 shipments.
India imported Efavirenz worth $216 USD from SINGAPORE across 10 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Efavirenz sourced from SINGAPORE include STRIDES PHARMA SCIENCE LIMITED. The largest buyer is STRIDES PHARMA SCIENCE LIMITED with $216 in imports across 10 shipments.
The total value of Efavirenz imports from SINGAPORE to India is $216 USD, across 10 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists